Novartis Ag Sample Contracts

Novartis Ag – DATE _27_ MARCH 2018 GLAXOSMITHKLINE PLC (January 30th, 2019)
Novartis Ag – Novartis AG Long Term Incentive Plan (March 15th, 2017)

Adopted by the Board of Directors on January 22, 2014 and amended thereafter Version effective in relation to awards made on or after January 1, 2017

Novartis Ag – Novartis AG Deferred Share Bonus Plan (March 15th, 2017)

Adopted by the Board of Directors on January 22, 2014 and amended on January 1, 2016 with effect in relation to awards made on or after that date

Novartis Ag – Contract (January 27th, 2016)

Confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission

Novartis Ag – Contract (January 27th, 2016)

Confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission

Novartis Ag – NOVARTIS AG and GLAXOSMITHKLINE PLC and GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS LIMITED DEED OF AMENDMENT AND RESTATEMENT relating to the (January 27th, 2016)
Novartis Ag – Contract (January 27th, 2016)

Confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission

Novartis Ag – NOVARTIS AG and GLAXOSMITHKLINE PLC DEED OF AMENDMENT AND RESTATEMENT relating to the (January 27th, 2016)

Schedule 8 Product Approvals and Product Applications Part 1 Terms relating to the Product Approvals and Product Applications 132

Novartis Ag – 21 November 2014 GLAXOSMITHKLINE PLC and NOVARTIS AG (January 27th, 2015)
Novartis Ag – Contract (January 27th, 2015)

Confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission

Novartis Ag – FIRST AMENDMENT TO STOCK AND ASSET PURCHASE AGREEMENT (January 27th, 2015)

THIS STOCK AND ASSET PURCHASE AGREEMENT (as it may be amended or supplemented from time to time in accordance with the terms hereof, this Agreement), dated as of April 22, 2014, is entered into by and between Novartis AG, a company incorporated under the laws of Switzerland (the Seller), and Eli Lilly and Company, a corporation organized under the laws of Indiana (the Purchaser; each of the Purchaser and the Seller is a Party and together are the Parties).

Novartis Ag – 9 October 2014 NOVARTIS AG and GLAXOSMITHKLINE PLC DEED OF AMENDMENT relating to the SHARE AND BUSINESS SALE AGREEMENT relating to the Vaccines Group, dated 22 April 2014 as amended and restated on 29 May 2014 (January 27th, 2015)
Novartis Ag – DEED OF AMENDMENT AND RESTATEMENT relating to the IMPLEMENTATION AGREEMENT dated 22 April 2014 (January 27th, 2015)
Novartis Ag – Contract (January 27th, 2015)

Confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission

Novartis Ag – Dated 26 October 2014 NOVARTIS AG and CSL LIMITED SHARE AND BUSINESS SALE AGREEMENT relating to the Flu Group (January 27th, 2015)
Novartis Ag – Novartis AG Deferred Share Bonus Plan Adopted by the Board of Directors on January 22, 2014 (September 12th, 2014)
Novartis Ag – Novartis AG Long Term Incentive Plan Adopted by the Board of Directors on January 22, 2014 (September 12th, 2014)
Novartis Ag – NOVARTIS CAPITAL CORPORATION Officer’s Certificate (February 21st, 2014)

I, Kenneth P. Schuster, being President of Novartis Capital Corporation (the “Company”), a Delaware corporation, pursuant to the resolutions duly adopted by the Board of Directors of the Company on February 7, 2014, hereby determine as follows that:

Novartis Ag – Amended 2002 Alcon Incentive Plan (As Amended December 1, 2010) (April 8th, 2011)
Novartis Ag – NOVARTIS CORPORATION 2011 STOCK INCENTIVE PLAN FOR NORTH AMERICAN EMPLOYEES (THE “PLAN”) (Effective January 1, 2011) (January 18th, 2011)
Novartis Ag – NOVARTIS CORPORATION 2001 STOCK INCENTIVE PLAN FOR NORTH AMERICAN EMPLOYEES (as amended and restated effective January 1, 2008) (October 29th, 2009)
Novartis Ag – AMENDED AND RESTATED NOVARTIS ADS DIRECT PLAN (March 5th, 2009)
Novartis Ag – Purchase and Option Agreement As of 6 April 2008 (this “Agreement”) Between Nestlé S.A. Avenue Nestlé, 55 1800 Vevey Switzerland (the “Seller”) and Novartis AG Lichtstrasse 35 4056 Basel Switzerland (the “Buyer”) Concerning the Sale and Purchase of Common Shares of Alcon, Inc. (the “Company”) owned by the Seller (January 28th, 2009)

WHEREAS, concurrently with the execution and delivery of this Agreement, the Buyer and the Seller are entering into a shareholders agreement, dated as of even date herewith (as amended from time to time, the “Shareholders Agreement”), providing for certain corporate governance matters of the Company and certain other agreements between the Buyer and the Seller;

Novartis Ag – Shareholders Agreement (January 28th, 2009)

WHEREAS, concurrently with the execution and delivery of this Agreement, the Seller and the Buyer have entered into the Purchase and Option Agreement dated as of 6 April 2008 (the “Purchase and Option Agreement”), concerning the sale by the Seller and the purchase by the Buyer of certain Common Shares;

Novartis Ag – Agreement As of 11 April 2007 (this “Agreement”) Between Novartis AG Lichtstrasse 35 4056 Basel Switzerland (the “Seller”) and Nestlé S.A. Avenue Nestlé, 55 1800 Vevey Switzerland (the “Buyer”) Concerning the Sale and Purchase of the Seller’s Gerber Business (January 28th, 2008)

WHEREAS, the Seller directly or indirectly owns all of the issued and outstanding share capital of (i) Gerber Products Company, a Michigan corporation (“Gerber Products”), (ii) Gerber Products Company of Puerto Rico, Inc., a company organized under the laws of Puerto Rico (“Gerber Puerto Rico”), (iii) Gerber Chile S.A., a company organized under the laws of Chile, (iv) Gerber Finance Company, a Delaware corporation, (v) Alima-Gerber S.A., a company organized under the laws of Poland (“Gerber Poland”), (vi) Gerber Holdings de Mexico SA de CV, a company organized under the laws of Mexico (“Gerber Holdings Mexico”), (vii) Productos Gerber SA de CV, a company organized under the laws of Mexico (“Gerber Mexico”), (viii) Productos Gerber de Centroamerica S.A., a company organized under the laws of Costa Rica, (ix) Novartis Nutrition de Venezuela S.A., a company organized under the laws of Venezuela (“Gerber Venezuela”), (x) Gerber Ingredients S.A., a company organized under the laws of Costa

Novartis Ag – Agreement As of 14 December 2006 (this "Agreement") Between Novartis AG Lichtstrasse 35 4056 Basel Switzerland (the "Seller") and Nestlé S.A. Avenue Nestlé, 55 1800 Vevey Switzerland (the "Buyer") Concerning the Sale and Purchase of the Seller's Medical Nutrition Business (January 31st, 2007)

WHEREAS, the Seller directly or indirectly owns all of the issued and outstanding share capital (the "Shares") of (i) Novartis Nutrition GmbH ("Nutrition GmbH Austria"), (ii) Novartis Nutrition S.A.S. ("Nutrition S.A.S."), (iii) Novartis Nutrition GmbH (Germany) ("Nutrition GmbH Germany"), (iv) Novartis Nutrition K.K. ("Nutrition K.K."), (v) Novartis Medical Nutrition (Sweden) AB ("Nutrition AB") and (vi) Novartis Nutrition Corporation ("Nutrition Corporation") (collectively, the "Companies"), and of the Asset Selling Subsidiaries (as defined below);

Novartis Ag – AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER (January 31st, 2007)

This AMENDMENT NO. 1 (this "AMENDMENT"), dated as of April 3, 2006, to the Agreement and Plan of Merger, dated as of October 30, 2005 (the "MERGER AGREEMENT"), by and among Novartis Corporation, a New York corporation and an indirect wholly owned subsidiary of Novartis AG ("Parent"), a Swiss corporation ("NOVARTIS CORP"), Novartis Biotech Partnership, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent AG ("MERGER Sub"), Chiron Corporation, a Delaware corporation ("CHIRON"), and for purposes of Section 10.14 thereof only, Parent.

Novartis Ag – NOVARTIS CORPORATION 2001 STOCK INCENTIVE PLAN FOR NORTH AMERICAN EMPLOYEES (as amended through December 31, 2005) (September 5th, 2006)
Novartis Ag – SHARE AND PARTNERSHIP INTEREST SALE AND TRANSFER AGREEMENT (January 30th, 2006)

The approval has to be declared towards the undersigned notary and will become effective upon its receipt by the notary. If the approval is declared by an authorized person, who, up to now, has only provided evidence of authorization towards the Purchaser by a none notarized authorization, a notarized version of the authorization (which was signed before a notary) has to be delivered to the undersigned notary as soon as reasonably possible and prior to the Closing Date as a subsequent exhibit to the agreement.

Novartis Ag – Employment Contract (January 30th, 2006)

Your Employment Contract consists of the employment conditions as set forth in this contract and the internal rules and regulations (attached or referred to herein), which constitute an integral part of this Contract.

Novartis Ag – AGREEMENT AND PLAN OF MERGER by and among NOVARTIS CORPORATION, NOVARTIS BIOTECH PARTNERSHIP, INC., (January 30th, 2006)

AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of October 30, 2005, by and among Novartis Corporation, a New York corporation (“Novartis”) and an indirect wholly owned subsidiary of Novartis AG, a stock corporation organized under the laws of Switzerland (“Parent”), Novartis Biotech Partnership, Inc., a Delaware corporation and a subsidiary of Novartis (“Merger Sub”), Chiron Corporation, a Delaware corporation (the “Company”), and, for purposes of Section 10.14 only, Parent.

Novartis Ag – AGREEMENT AND PLAN OF MERGER by and among NOVARTIS CORPORATION ZODNAS ACQUISITION CORP. an indirect, wholly owned subsidiary of Novartis Corporation EON LABS, INC. and for purposes of Section 10.12 only, NOVARTIS AG Dated as of February 20, 2005 (January 30th, 2006)

This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of this 20th day of February 2005, by and among Novartis Corporation, a New York corporation (“Novartis”), Zodnas Acquisition Corp., an indirect, wholly owned Subsidiary of Novartis (“Merger Sub”), Eon Labs, Inc., a Delaware corporation (the “Company”) and, for purposes of Section 10.12 only, Novartis AG, a Swiss Company (“Parent”).

Novartis Ag – AGREEMENT FOR PURCHASE AND SALE OF STOCK OF EON LABS, INC. by and between NOVARTIS CORPORATION, as PURCHASER, SANTO HOLDING (DEUTSCHLAND) GMBH, as SELLER, AND, FOR THE PURPOSES OF SECTION 12 ONLY, NOVARTIS AG Dated as of February 20, 2005 (January 30th, 2006)

Novartis Corporation, a company organized under the laws of the State of New York (“Purchaser”) with its principal office located at 608 Fifth Avenue, New York, NY 10020 USA;

Novartis Ag – 2001 STOCK INCENTIVE PLAN (October 1st, 2004)

Exhibit 10 NOVARTIS CORPORATION 2001 STOCK INCENTIVE PLAN FOR NORTH AMERICAN EMPLOYEES (as amended through February 4, 2004) 1. Purpose The purpose of the Plan is to provide a means through which the Company and its Subsidiaries may attract able persons to enter and remain in the employ or in a consulting relationship with the Company and its Subsidiaries and to provide a means whereby they can acquire and maintain Stock ownership, or be paid incentive compensation measured by reference to the value of Stock, thereby strengthening their commitment to the welfare of the Company and its Subsidiaries and promoting an identity of interest between shareholders of Novartis AG and these employees, directors and consultants. So that the appropriate incentive can be provided, the Plan provides for grantin

Novartis Ag – QuickLinks -- Click here to rapidly navigate through this document (January 30th, 2004)

I am pleased to offer you the following terms for your employment with The Novartis Institute for Biomedical Research, Inc. ("NIBR")